BRAIN Biotech AG
XETRA:BNN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (4.2), the stock would be worth €-0.14 (105% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -82.8 | €2.76 |
0%
|
| 3-Year Average | 4.2 | €-0.14 |
-105%
|
| 5-Year Average | 4.9 | €-0.16 |
-106%
|
| Industry Average | 1.2 | €-0.04 |
-101%
|
| Country Average | 1.7 | €-0.06 |
-102%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| DE |
|
BRAIN Biotech AG
XETRA:BNN
|
60.3m EUR | -82.8 | -5.7 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
13.5T JPY | 3 | 28.4 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
78.7B USD | 17.1 | 30.7 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
72.4B USD | 7.4 | 34.9 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | 0.7 | 10.5 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
282.8B CNY | 2.6 | 21.5 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
25.7B CHF | 5.6 | 23.9 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 11.8 | 54.8 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.3T INR | 11.9 | 60.7 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
23.4B USD | 2.9 | 14.8 | |
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR | 2.7 | 17.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.1 |
| Median | 1.7 |
| 70th Percentile | 2.8 |
| Max | 125.7 |
Other Multiples
BRAIN Biotech AG
Glance View
BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen and currently employs 293 full-time employees. The company went IPO on 2016-02-09. Research & Development activities focus on bioactive natural compounds, tailored enzymes and high-performance microorganisms.
